Amphenol, Charts

Amphenol Charts New Course with Norwitt at Helm as AI Revenue Surges but Stock Takes a Hit

22.05.2026 - 01:03:55 | boerse-global.de

Amphenol shares slide nearly 20% amid AI data center boom, as CEO transition and insider selling offset record $8.1B revenue forecast and robust 1.24 book-to-bill ratio.

Amphenol Charts New Course with Norwitt at Helm as AI Revenue Surges but Stock Takes a Hit - Foto: über boerse-global.de
Amphenol Charts New Course with Norwitt at Helm as AI Revenue Surges but Stock Takes a Hit - Foto: über boerse-global.de

The disconnect between Amphenol’s operational momentum and its stock price has rarely been wider. While the electronics giant is riding a wave of demand from AI data centers that is pushing second-quarter revenue toward $8.1 billion — a jump of as much as 45% year-on-year — its shares have slumped nearly 20% over the past month. The stock recently changed hands at €105.92, skidding below both its 50-day and 200-day moving averages after touching €106.32 earlier in the week. Market observers see the pullback as a potential undervaluation, but the selling pressure has been relentless.

Behind the scenes, the company is executing a carefully choreographed leadership transition. CEO R. Adam Norwitt will add the role of chairman at the annual general meeting in May, taking over from Martin H. Loeffler, who leaves the board after more than five decades with the group and 28 years as its head. The timing of the handover aligns with Amphenol’s aggressive push into AI infrastructure and data center connectivity — where its high-speed copper and fiber optic solutions are in heavy demand. The book-to-bill ratio stands at a robust 1.24, meaning for every dollar billed, $1.24 in new orders flows in.

Insiders, however, have been trimming their own exposure. Over the past three months, company executives sold shares worth $18.7 million, a signal that at least some in the C-suite are taking chips off the table even as the business booms. Institutions continue to dominate the shareholder register, controlling roughly 97% of Amphenol’s outstanding stock. Their moves have been mixed: the Rathbones Group cut its position by 4.3% but still retains a hefty block, while Gamco Investors bought in with a near-$5 million stake and GSA Capital Partners nearly tripled its holding.

Should investors sell immediately? Or is it worth buying Amphenol?

Amphenol is also shoring up its balance sheet to fund expansion. It placed €1.1 billion in senior notes, with the proceeds earmarked for the acquisition of CommScope’s relevant business unit and for advancing its optical technology capabilities. Shareholders are not being overlooked either: the board confirmed a quarterly dividend of $0.25 per share, with the next payout scheduled for July 2026. The fresh capital, combined with the $8.1 billion revenue run-rate, provides ample firepower for the company’s next growth phase.

For all the near-term turbulence — the stock is still up roughly 40% on a one-year view — the question is whether the technical damage can heal quickly. With the shares trading below both the 50-day and 200-day lines and volatility persisting, the path of least resistance appears lower. Yet the institutional backbone, the leadership clarity, and the AI-driven order surge give Amphenol a foundation that many of its peers would envy. The second half of the year will test whether those fundamentals can finally arrest the slide.

Ad

Amphenol Stock: New Analysis - 22 May

Fresh Amphenol information released. What's the impact for investors? Our latest independent report examines recent figures and market trends.

Read our updated Amphenol analysis...

So schätzen die Börsenprofis Amphenol Aktien ein!

<b>So schätzen die Börsenprofis Amphenol Aktien ein!</b>
Seit 2005 liefert der Börsenbrief trading-notes verlässliche Anlage-Empfehlungen – dreimal pro Woche, direkt ins Postfach. 100% kostenlos. 100% Expertenwissen. Trage einfach deine E-Mail Adresse ein und verpasse ab heute keine Top-Chance mehr. Jetzt abonnieren.
Für. Immer. Kostenlos.
en | US0320951017 | AMPHENOL | boerse | 69395089 |